Xilio Therapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-80.8M | $-81.9M | $1.1M | $5.0M |
| FY2022 | $-75.7M | $-77.6M | $1.9M | $8.4M |
| FY2023 | $-68.6M | $-69.1M | $486.0K | $7.4M |
| FY2024 | $-18.4M | $-18.4M | $36.0K | $6.4M |
| FY2025 | $-5.0M | $-5.5M | $518.0K | $6.9M |